Wednesday, February 4, 2015

Guardant Health Finds $50M

Redwood City-based Guardant Health, a developer of genome-based, cancer screening tests, said Tuesday that it has raised $50M in its Series C funding round. The funding was led by Lightspeed Venture Partners, and also included Formation 8, Khosla Ventures, and Sequoia Capital. The company says it has now raised a total of $100M. The company develops a cancer test which does not require a biopsy. More information »